Structure

Physi-Chem Properties

Molecular Weight:  762.21
Volume:  699.076
LogP:  3.152
LogD:  4.116
LogS:  -1.699
# Rotatable Bonds:  4
TPSA:  203.43
# H-Bond Aceptor:  14
# H-Bond Donor:  5
# Rings:  6
# Heavy Atoms:  18

MedChem Properties

QED Drug-Likeness Score:  0.178
Synthetic Accessibility Score:  4.478
Fsp3:  0.594
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.755
MDCK Permeability:  1.5039493518997915e-05
Pgp-inhibitor:  0.019
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.016
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.977
Plasma Protein Binding (PPB):  55.53378677368164%
Volume Distribution (VD):  3.296
Pgp-substrate:  19.395488739013672%

ADMET: Metabolism

CYP1A2-inhibitor:  0.084
CYP1A2-substrate:  0.043
CYP2C19-inhibitor:  0.088
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.156
CYP2C9-substrate:  0.027
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.034
CYP3A4-inhibitor:  0.058
CYP3A4-substrate:  0.832

ADMET: Excretion

Clearance (CL):  2.276
Half-life (T1/2):  0.11

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  1.0
Drug-inuced Liver Injury (DILI):  0.996
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.097
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.096
Carcinogencity:  0.036
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.682

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC120917

Natural Product ID:  NPC120917
Common Name*:   Ulithiacyclamide
IUPAC Name:   n.a.
Synonyms:   Ulithiacyclamide
Standard InCHIKey:  FSUFGKVPTHSJKC-OFGHLPPXSA-N
Standard InCHI:  InChI=1S/C32H42N8O6S4/c1-13(2)7-17-31-37-19(9-47-31)25(41)35-22-12-50-49-11-21(29-39-23(15(5)45-29)27(43)33-17)36-26(42)20-10-48-32(38-20)18(8-14(3)4)34-28(44)24-16(6)46-30(22)40-24/h9-10,13-18,21-24H,7-8,11-12H2,1-6H3,(H,33,43)(H,34,44)(H,35,41)(H,36,42)/t15-,16-,17-,18-,21-,22-,23+,24+/m1/s1
SMILES:  CC(C)C[C@@H]1c2nc(cs2)C(=N[C@@H]2CSSC[C@H](C3=N[C@@H]([C@@H](C)O3)C(=N1)O)N=C(c1csc([C@@H](CC(C)C)N=C([C@@H]3[C@@H](C)OC2=N3)O)n1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL502961
PubChem CID:   44593594
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0001995] Cyclic peptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[1593285]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[2095371]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[2809606]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[7623037]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[9868162]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus IC50 = 0.35 ug.mL-1 PMID[479911]
NPT404 Cell Line CCRF-CEM Homo sapiens IC50 = 0.01 ug.mL-1 PMID[479911]
NPT6463 Cell Line MRC5CV1 Homo sapiens IC50 = 0.22 ug.mL-1 PMID[479911]
NPT550 Cell Line T-24 Homo sapiens IC50 = 0.15 ug.mL-1 PMID[479911]
NPT6463 Cell Line MRC5CV1 Homo sapiens IC50 = 0.04 ug.mL-1 PMID[479911]
NPT550 Cell Line T-24 Homo sapiens IC50 = 0.1 ug.mL-1 PMID[479911]
NPT91 Cell Line KB Homo sapiens IC50 = 0.035 ug.mL-1 PMID[479913]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 3000.0 nM PMID[479912]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC120917 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9603 High Similarity NPC74917
0.9286 High Similarity NPC89592
0.9274 High Similarity NPC51692
0.9032 High Similarity NPC135558
0.8968 High Similarity NPC267605
0.872 High Similarity NPC214375
0.775 Intermediate Similarity NPC174652
0.7688 Intermediate Similarity NPC475330
0.764 Intermediate Similarity NPC263485
0.764 Intermediate Similarity NPC229160
0.764 Intermediate Similarity NPC25316
0.7622 Intermediate Similarity NPC103268
0.7551 Intermediate Similarity NPC475390
0.7532 Intermediate Similarity NPC237219
0.7516 Intermediate Similarity NPC475534
0.7516 Intermediate Similarity NPC476080
0.7407 Intermediate Similarity NPC161242
0.7208 Intermediate Similarity NPC50274
0.7099 Intermediate Similarity NPC164006
0.7099 Intermediate Similarity NPC476103
0.7037 Intermediate Similarity NPC24990
0.6954 Remote Similarity NPC469801
0.6937 Remote Similarity NPC522
0.6937 Remote Similarity NPC56058
0.6886 Remote Similarity NPC132662
0.6829 Remote Similarity NPC34319
0.6748 Remote Similarity NPC222391
0.6728 Remote Similarity NPC201014
0.6728 Remote Similarity NPC110129
0.6727 Remote Similarity NPC256912
0.6606 Remote Similarity NPC475554
0.6603 Remote Similarity NPC319751
0.6543 Remote Similarity NPC217981
0.6519 Remote Similarity NPC473398
0.6509 Remote Similarity NPC134480
0.6478 Remote Similarity NPC119481
0.6471 Remote Similarity NPC473704
0.6364 Remote Similarity NPC216720
0.6325 Remote Similarity NPC210424
0.6044 Remote Similarity NPC329961
0.6 Remote Similarity NPC96016
0.5978 Remote Similarity NPC165538
0.5956 Remote Similarity NPC122427
0.5954 Remote Similarity NPC101980
0.5954 Remote Similarity NPC470146
0.5954 Remote Similarity NPC97078
0.5738 Remote Similarity NPC49051
0.5731 Remote Similarity NPC315252
0.568 Remote Similarity NPC14101

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC120917 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6929 Remote Similarity NPD9579 Approved
0.581 Remote Similarity NPD2957 Phase 2
0.5706 Remote Similarity NPD6915 Approved
0.5658 Remote Similarity NPD6121 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data